Younossi ZM - Search Results

1

Hepatitis C: an update on the silent epidemic.

Sarbah SA, Younossi ZM. Sarbah SA, et al. Among authors: younossi zm. J Clin Gastroenterol. 2000 Mar;30(2):125-43. doi: 10.1097/00004836-200003000-00005. J Clin Gastroenterol. 2000. PMID: 10730918 Review.

2

Triple combination of interferon alpha-2b, ribavirin, and amantadine for treatment of chronic hepatitis C.

Younossi ZM, Mullen KD, Hodnick S, Barnes DS, Carey WD, McCullough AC, Easley K, Gramlich T, Liebermann BY. Younossi ZM, et al. J Clin Gastroenterol. 2003 May-Jun;36(5):427-30. doi: 10.1097/00004836-200305000-00014. J Clin Gastroenterol. 2003. PMID: 12702987

3

Immunogenicity of hepatitis A vaccine in decompensated liver disease.

Dumot JA, Barnes DS, Younossi Z, Gordon SM, Avery RK, Domen RE, Henderson JM, Carey WD. Dumot JA, et al. Am J Gastroenterol. 1999 Jun;94(6):1601-4. doi: 10.1111/j.1572-0241.1999.01150.x. Am J Gastroenterol. 1999. PMID: 10364031 Clinical Trial.

4

The role of liver biopsy in chronic hepatitis C.

Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes D, Easley K. Saadeh S, et al. Hepatology. 2001 Jan;33(1):196-200. doi: 10.1053/jhep.2001.20534. Hepatology. 2001. PMID: 11124836

5

Cost effectiveness of screening for hepatitis C virus in asymptomatic, average-risk adults.

Singer ME, Younossi ZM. Singer ME, et al. Among authors: younossi zm. Am J Med. 2001 Dec 1;111(8):614-21. doi: 10.1016/s0002-9343(01)00951-2. Am J Med. 2001. PMID: 11755504

6

Clinical features and natural history of nonalcoholic steatosis syndromes.

Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Falck-Ytter Y, et al. Among authors: younossi zm. Semin Liver Dis. 2001;21(1):17-26. doi: 10.1055/s-2001-12926. Semin Liver Dis. 2001. PMID: 11296693 Review.

7

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.

Ong JP, Younossi ZM, Speer C, Olano A, Gramlich T, Boparai N. Ong JP, et al. Among authors: younossi zm. Liver. 2001 Aug;21(4):266-71. doi: 10.1034/j.1600-0676.2001.021004266.x. Liver. 2001. PMID: 11454190

8

Hepatitis C, cryoglobulinemia, and cutaneous vasculitis associated with unusual and serious manifestations.

Méndez P, Saeian K, Reddy KR, Younossi ZM, Kerdel F, Badalamenti S, Jeffers LJ, Schiff ER. Méndez P, et al. Among authors: younossi zm. Am J Gastroenterol. 2001 Aug;96(8):2489-93. doi: 10.1111/j.1572-0241.2001.04059.x. Am J Gastroenterol. 2001. PMID: 11513197

9

Study of host and virological factors of patients with chronic HCV infection and associated laboratory or clinical autoimmune manifestations.

Vassilopoulos D, Younossi ZM, Hadziyannis E, Boparai N, Yen-Lieberman B, Hsi E, Villa-Forte A, Ball E, Kimberly RP, Calabrese LH. Vassilopoulos D, et al. Among authors: younossi zm. Clin Exp Rheumatol. 2003 Nov-Dec;21(6 Suppl 32):S101-11. Clin Exp Rheumatol. 2003. PMID: 14740435

10

Cost effectiveness of interferon alpha2b combined with ribavirin for the treatment of chronic hepatitis C.

Younossi ZM, Singer ME, McHutchison JG, Shermock KM. Younossi ZM, et al. Hepatology. 1999 Nov;30(5):1318-24. doi: 10.1002/hep.510300518. Hepatology. 1999. PMID: 10534357

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results